Showing 1 - 9 results of 9 for search 'Marygorret Obonyo', query time: 0.05s Refine Results
  1. 1
    Mechanism of antibacterial activity of liposomal linolenic acid against Helicobacter pylori.

    Mechanism of antibacterial activity of liposomal linolenic acid against Helicobacter pylori. by Sung Woo Jung, Soracha Thamphiwatana, Liangfang Zhang, Marygorret Obonyo

    Published 2015-01-01
    Get full text
    Article
  2. 2
    Microbiome Signatures in a Fast- and Slow-Progressing Gastric Cancer Murine Model and Their Contribution to Gastric Carcinogenesis

    Microbiome Signatures in a Fast- and Slow-Progressing Gastric Cancer Murine Model and Their Contribution to Gastric Carcinogenesis by Prerna Bali, Joanna Coker, Ivonne Lozano-Pope, Karsten Zengler, Marygorret Obonyo

    Published 2021-01-01
    Get full text
    Article
  3. 3
    A Bioluminescence-Based Drug Screen Identifies Activities of Fexinidazole and Its Metabolites against <i>Helicobacter pylori</i>

    A Bioluminescence-Based Drug Screen Identifies Activities of Fexinidazole and Its Metabolites against <i>Helicobacter pylori</i> by Abdolhakim Mohamed, John N Chilingerian, Prerna Bali, Marygorret Obonyo, Anjan Debnath

    Published 2022-11-01
    Get full text
    Article
  4. 4
    Comparison of lipopolysaccharides composition of two different strains of Helicobacter pylori

    Comparison of lipopolysaccharides composition of two different strains of Helicobacter pylori by Kristy Leker, Ivonne Lozano-Pope, Keya Bandyopadhyay, Biswa P. Choudhury, Marygorret Obonyo

    Published 2017-12-01
    Get full text
    Article
  5. 5
    Protocol to establish an accelerated murine model for Helicobacter-induced gastric cancer

    Protocol to establish an accelerated murine model for Helicobacter-induced gastric cancer by Prerna Bali, Ivonne Lozano-Pope, Jonathan Hernandez, Monica V. Estrada, Christopher Benner, Marygorret Obonyo

    Published 2024-09-01
    Get full text
    Article
  6. 6
    Genomically Silent Refractory Gastric Cancer in a Young Patient Exhibits Overexpression of CXCL5

    Genomically Silent Refractory Gastric Cancer in a Young Patient Exhibits Overexpression of CXCL5 by Jonathan Hernandez, Michael A. Turner, Prerna Bali, Mojgan Hosseini, Michael Bouvet, Kaitlyn Kelly, Marygorret Obonyo

    Published 2022-07-01
    Get full text
    Article
  7. 7
    TRIF-IFN-I pathway in Helicobacter-induced gastric cancer in an accelerated murine disease model and patient biopsies

    TRIF-IFN-I pathway in Helicobacter-induced gastric cancer in an accelerated murine disease model and patient biopsies by Prerna Bali, Ivonne Lozano-Pope, Jonathan Hernandez, Monica V. Estrada, Maripat Corr, Michael A. Turner, Michael Bouvet, Christopher Benner, Marygorret Obonyo

    Published 2024-04-01
    Get full text
    Article
  8. 8
    Micromotor-enabled active drug delivery for in vivo treatment of stomach infection

    Micromotor-enabled active drug delivery for in vivo treatment of stomach infection by Berta Esteban-Fernández de Ávila, Pavimol Angsantikul, Jinxing Li, Miguel Angel Lopez-Ramirez, Doris E. Ramírez-Herrera, Soracha Thamphiwatana, Chuanrui Chen, Jorge Delezuk, Richard Samakapiruk, Valentin Ramez, Marygorret Obonyo, Liangfang Zhang, Joseph Wang

    Published 2017-08-01
    Get full text
    Article
  9. 9
    Author correction: Micromotor-enabled active drug delivery for in vivo treatment of stomach infection

    Author correction: Micromotor-enabled active drug delivery for in vivo treatment of stomach infection by Berta Esteban-Fernández de Ávila, Pavimol Angsantikul, Jinxing Li, Miguel Angel Lopez-Ramirez, Doris E. Ramírez-Herrera, Soracha Thamphiwatana, Chuanrui Chen, Jorge Delezuk, Richard Samakapiruk, Valentin Ramez, Marygorret Obonyo, Liangfang Zhang, Joseph Wang

    Published 2017-10-01
    Get full text
    Article

Search Tools: